Supernus Pharmaceuticals SUPN Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Supernus Pharmaceuticals (SUPN) reported increase (decrease) in prepaid expense and other assets of $12.43M in Q1 2026.
- How has Supernus Pharmaceuticals's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Supernus Pharmaceuticals's increase (decrease) in prepaid expense and other assets increased by 268.6% year-over-year, from -$7.37M to $12.43M.
- What is the long-term trend for Supernus Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2025), Supernus Pharmaceuticals's increase (decrease) in prepaid expense and other assets has grown at a 3.5% compound annual growth rate (CAGR), from -$12.3M to $13.18M.